Persistent nonmalignant pain: implications and opportunities for managed care
Emons, M.F.
Managed Care 12(8 Suppl Improving Pain): 2-7
2003
ISSN/ISBN: 1062-3388 PMID: 13677057 Document Number: 561943
Document emailed within 1 workday
Related Documents
Watkins, A.; Wasmann, S.; Dodson, L.; Hayes, M. 2004: An evaluation of the care provided to patients prescribed controlled substances for chronic nonmalignant pain at an academic family medicine center Family Medicine 36(7): 487-489Cooper, S.R. 1997: Role and function within managed care organizations: opportunities for nurse managers Seminars for Nurse Managers 5(3): 129-132
Derrell, R. 1999: Implications of Medicare reform on managed care Managed Care Interface 12(8): 42-43
Thind, A. 2002: Managed care and developing countries: what are the equity implications? National Medical Journal of India 15(3): 121-123
Giaquinta, D. 2002: Managed care implications of the approval of generic or over-the-counter nonsedating antihistamines Managed Care Interface 15(6): 31-34
Sano, M. 2004: Economic effect of cholinesterase inhibitor therapy: implications for managed care Managed Care Interface 17(8): 44-49
Barkin, R.L. 2001: Pharmacotherapy for nonmalignant pain American Family Physician 63(5): 848
Philip, D.J. 1997: Ethics of managed care: clinical and administrative implications for medical group practices College Review 14(1): 61-80
Marcus, D.A. 2000: Treatment of nonmalignant chronic pain American Family Physician 61(5): 1331-1338; 1345-1346
Linden, A.; Goldberg, S. 2007: The case-mix of chronic illness hospitalization rates in a managed care population: implications for health management programmes Journal of Evaluation in Clinical Practice 13(6): 947-951
Alfvén, G.ös. 2012: Psychosomatic pain diagnosis should be based on established criteria. can provide opportunities for improved care Lakartidningen 109(5): 224-227
Grandinetti, D. 1998: Managed care 1998: Medicare managed care. Partner with an HMO? There's more to it than money Medical Economics 75(6): 107-108; 113-4; 117-118
Perrot, S.; Bannwarth, B.; Bertin, P.; Javier, R.M.; Glowinski, J.; Le Bars, M.; Treves, R. 1999: Use of morphine in nonmalignant joint pain: the Limoges recommendations. The French Society for Rheumatology Revue du Rhumatisme 66(11): 571-576
Reinhardt, U.E. 1995: Managed care, capitation, and managed competition: a brief primer Compendium of Continuing Education in Dentistry Spec No: 6-10
Rivo, M.L.; Mays, H.L.; Katzoff, J.; Kindig, D.A. 1995: Managed health care. Implications for the physician workforce and medical education. Council on Graduate Medical Education JAMA 274(9): 712-715
Türp, J.C.; Kowalski, C.J.; Stohler, C.S. 1997: Pain descriptors characteristic of persistent facial pain Journal of Orofacial Pain 11(4): 285-290
Davidson, P.; Introna, K.; Daly, J.; Paull, G.; Jarvis, R.; Angus, J.; Wilds, T.; Cockburn, J.; Dunford, M.; Dracup, K. 2003: Cardiorespiratory nurses' perceptions of palliative care in nonmalignant disease: data for the development of clinical practice American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 12(1): 47-53
Webb, L.; Shah, P.K.; Harisiades, J.P.; Boudos, R.; Agrawal, R. 2015: Health care transition from pediatric care to adult care: opportunities and challenges under the Affordable Care Act Journal of Pediatric Rehabilitation Medicine 8(1): 53-64
Lavrovskiĭ, V.A.; Viksler, V.K. 1979: Immunological properties of malignant and nonmalignant L-cell sublines. I. Obtaining a malignant L-cell subline and its immunological cross reactivity with nonmalignant cells Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 10: 73-76
Danzig, J.; Navarro, R.; Inami, D.; Morreale, A.; Tokayer, A.; Wong, W.; Compton, J.; Page, R.N.; Sweet, F.B. 2001: The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion Managed Care Interface Suppl B: 13-20; Discussion 24-7 31-3